304 related articles for article (PubMed ID: 11166970)
1. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats.
Zurek JR; Nadeson R; Goodchild CS
Pain; 2001 Feb; 90(1-2):57-63. PubMed ID: 11166970
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems.
Nadeson R; Tucker A; Bajunaki E; Goodchild CS
Br J Anaesth; 2002 May; 88(5):685-91. PubMed ID: 12067007
[TBL] [Abstract][Full Text] [Related]
3. 5-HT spinal antinociception involves mu opioid receptors: cross tolerance and antagonist studies.
Goodchild CS; Guo Z; Freeman J; Gent JP
Br J Anaesth; 1997 May; 78(5):563-9. PubMed ID: 9175973
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Dec; 99(6):1409-14. PubMed ID: 14639157
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive actions of intrathecal xylazine: interactions with spinal cord opioid pathways.
Goodchild CS; Guo Z; Davies A; Gent JP
Br J Anaesth; 1996 Apr; 76(4):544-51. PubMed ID: 8652328
[TBL] [Abstract][Full Text] [Related]
6. Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
Chen SR; Pan HL
Anesthesiology; 2003 Jan; 98(1):217-22. PubMed ID: 12503000
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites.
Narita M; Imai S; Itou Y; Yajima Y; Suzuki T
Life Sci; 2002 Apr; 70(20):2341-54. PubMed ID: 12150199
[TBL] [Abstract][Full Text] [Related]
8. The effect of benfotiamine on mu-opioid receptor mediated antinociception in experimental diabetes.
Nacitarhan C; Minareci E; Sadan G
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):173-8. PubMed ID: 24643695
[TBL] [Abstract][Full Text] [Related]
9. Relative contributions of peripheral versus supraspinal or spinal opioid receptors to the antinociception of systemic opioids.
Khalefa BI; Shaqura M; Al-Khrasani M; Fürst S; Mousa SA; Schäfer M
Eur J Pain; 2012 May; 16(5):690-705. PubMed ID: 22337491
[TBL] [Abstract][Full Text] [Related]
10. Magnesium ions and opioid agonist activity in streptozotocin-induced hyperalgesia.
Bujalska M; Malinowska E; Makulska-Nowak H; Gumułka SW
Pharmacology; 2008; 82(3):180-6. PubMed ID: 18701828
[TBL] [Abstract][Full Text] [Related]
11. Spinal-supraspinal and intrinsic μ-opioid receptor agonist-norepinephrine reuptake inhibitor (MOR-NRI) synergy of tapentadol in diabetic heat hyperalgesia in mice.
Christoph T; Schröder W; Tallarida RJ; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2013 Dec; 347(3):794-801. PubMed ID: 24051022
[TBL] [Abstract][Full Text] [Related]
12. Spinal orexin-1 receptors mediate anti-hyperalgesic effects of intrathecally-administered orexins in diabetic neuropathic pain model rats.
Kajiyama S; Kawamoto M; Shiraishi S; Gaus S; Matsunaga A; Suyama H; Yuge O
Brain Res; 2005 May; 1044(1):76-86. PubMed ID: 15862792
[TBL] [Abstract][Full Text] [Related]
13. Blocking mu opioid receptors in the spinal cord prevents the analgesic action by subsequent systemic opioids.
Chen SR; Pan HL
Brain Res; 2006 Apr; 1081(1):119-25. PubMed ID: 16499888
[TBL] [Abstract][Full Text] [Related]
14. [Met]enkephalin in the spinal cord is involved in the antinociception induced by intracerebroventricularly-administered etorphine in the mouse.
Xu JY; Tseng LF
Neuroscience; 1997 Sep; 80(2):579-85. PubMed ID: 9284359
[TBL] [Abstract][Full Text] [Related]
15. Spinal GABAB receptors mediate antinociceptive actions of cholinergic agents in normal and diabetic rats.
Chen SR; Pan HL
Brain Res; 2003 Mar; 965(1-2):67-74. PubMed ID: 12591121
[TBL] [Abstract][Full Text] [Related]
16. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
[TBL] [Abstract][Full Text] [Related]
17. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia.
Bujalska M; Winecka R; Gumułka SW
Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the spinal actions of the mu-opioid remifentanil with alfentanil and morphine in the rat.
Buerkle H; Yaksh TL
Anesthesiology; 1996 Jan; 84(1):94-102. PubMed ID: 8572360
[TBL] [Abstract][Full Text] [Related]
19. Participation of ATP-sensitive K+ channels in the peripheral antinociceptive effect of fentanyl in rats.
Rodrigues AR; Castro MS; Francischi JN; Perez AC; Duarte ID
Braz J Med Biol Res; 2005 Jan; 38(1):91-7. PubMed ID: 15665994
[TBL] [Abstract][Full Text] [Related]
20. Fentanyl produces an anti-hyperalgesic effect through the suppression of sodium channels in mice with painful diabetic neuropathy.
Tanaka K; Nakanishi Y; Sekino S; Ikegami M; Ikeda H; Kamei J
Eur J Pharmacol; 2014 Jun; 733():68-74. PubMed ID: 24704555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
